NasdaqHealth CareHealth Care ServicesS&P SmallCap 600
$7.34
-0.22 (-2.91%)
Close of Nov 06, 2026 · end-of-day data
ALHC 8-K filings in 2026
Every material Form 8-K Alignment Healthcare filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Alignment Healthcare reported third-quarter 2026 total revenue of $1,358.3 million, up 36.7% year-over-year, and membership of approximately 301,200, up 31.2%. Profit fell, with a net loss of $8.1 million compared with net income of $3.7 million a year earlier, and adjusted EBITDA down 32.8%. The company lowered its full-year 2026 adjusted gross profit and adjusted EBITDA guidance because of higher medical costs, which weighs on shareholders' expectations for profitability.
Q3 2026 total revenue was $1,358.3 million, up 36.7% year-over-year; net loss was $8.1 million versus net income of $3.7 million a year earlier
Medical benefits ratio based on adjusted gross profit rose to 89.5%, an increase of approximately 240 basis points year-over-year
Full-year 2026 adjusted gross profit guidance is no less than $575 million and adjusted EBITDA guidance is no less than $100 million, both lowered; full-year revenue guidance was raised to no less than $5,245 million
Fourth-quarter 2026 guidance calls for adjusted EBITDA of $(28) million, a loss, on revenue of $1,316 million
Alignment Healthcare reported second-quarter 2026 total revenue of $1,335.6 million, up 31.6% year-over-year, and net income of $36.6 million, compared with $15.7 million a year earlier. The company raised the midpoint of all its full-year 2026 guidance metrics, including membership, revenue, adjusted gross profit and adjusted EBITDA.
Q2 2026 total revenue was $1,335.6 million, up 31.6% year-over-year; health plan membership was about 294,100, up 31.5%.
Net income was $36.6 million versus $15.7 million; diluted EPS was $0.17 versus $0.07 a year earlier.
Adjusted EBITDA was $68.1 million, a 5.1% margin and up 48.4% year-over-year.
Full-year 2026 guidance: revenue $5,195 million to $5,225 million; adjusted EBITDA $145 million to $163 million.
Alignment Healthcare reported first-quarter 2026 total revenue of $1,235.2 million, up 33.3% year-over-year, and net income of $11.4 million, compared with a net loss of $9.4 million a year earlier. The company also raised the midpoint of its membership, revenue, adjusted gross profit and adjusted EBITDA guidance for 2026, which shows a higher outlook alongside the profit improvement.
Total revenue was $1,235.2 million for the quarter ended March 31, 2026, up 33.3% from the prior-year quarter.
Net income was $11.4 million, versus a $9.4 million net loss in Q1 2025; diluted EPS was $0.05.
Adjusted EBITDA was $37.9 million, up 87.6% year-over-year; health plan membership was about 284,800, up 30.9%.
Full-year 2026 revenue guidance is $5.16 billion to $5.205 billion, and adjusted EBITDA guidance is $138 million to $163 million.
Alignment Healthcare disclosed an underwritten offering in which a selling stockholder, not the company, sold 13,167,733 shares of common stock through J.P. Morgan Securities LLC. The offering closed on March 4, 2026, and the company said it will receive none of the proceeds, so the deal does not add new shares or cash to the company.
Underwriting agreement dated March 2, 2026, with J.P. Morgan Securities LLC and the selling stockholder
13,167,733 shares of common stock offered by the selling stockholder
Closing and delivery of shares took place March 4, 2026
Company will not receive any proceeds from the sale
Alignment Healthcare reported fourth-quarter 2025 total revenue of $1,012.8 million, up 44.4%, and a net loss of $11.0 million, compared with a $31.1 million loss a year earlier. For full-year 2025, revenue was $3.95 billion, up 46.1%, and the net loss narrowed to $1.0 million from $128.1 million. The company guided 2026 revenue to $5.14 billion to $5.19 billion and adjusted EBITDA to $133 million to $163 million, which signals expected continued growth and a path toward profitability for shareholders.
Q4 2025 total revenue was $1,012.8 million, up 44.4%; net loss was $11.0 million versus $31.1 million a year earlier.
Full-year 2025 revenue was $3.95 billion, up 46.1%; net loss was $1.0 million versus $128.1 million in 2024.
2026 guidance: revenue of $5.14 billion to $5.19 billion, adjusted EBITDA of $133 million to $163 million, and 292,000 to 298,000 health plan members.
Health plan membership guidance was raised by 2,000 at the midpoint; membership at the end of Q4 2025 was about 236,300, up 25.0%.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Alignment Healthcare filing is on SEC EDGAR ↗. 8-K briefs of other companies →